该药为E-选择素抑制剂,以内皮细胞为靶点,阻断骨髓细胞与白血病髓样细胞的粘附。
在对 388 名复发/难治性急性髓系白血病 (AML) 患者进...查看全文
Glycomimetics(GLYC)05-07 04:05
$Glycomimetics(GLYC)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001558370-24-006793 Act: 34 Size: 7 MB 网页链接查看全文
Glycomimetics(GLYC)05-02 04:35
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011861 Size: 5 KB 网页链接查看全文
Glycomimetics(GLYC)05-02 20:35
$Glycomimetics(GLYC)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001558370-24-006459 Act: 34 Size: 320 KB 网页链接查看全文
Glycomimetics(GLYC)05-02 04:35
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011872 Size: 5 KB 网页链接查看全文
Glycomimetics(GLYC)05-02 04:35
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011867 Size: 5 KB 网页链接查看全文
Glycomimetics(GLYC)05-02 04:35
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011862 Size: 5 KB 网页链接查看全文
Glycomimetics(GLYC)06-04 21:35
$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-008882 Act: 34 Size: 8 MB 网页链接查看全文
Glycomimetics(GLYC)05-02 04:35
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011860 Size: 5 KB 网页链接查看全文
皮神超级欧2021-02-23 23:23
$Glycomimetics(GLYC)$ 什么情况下工作了15年的副主席,医学方面的执行主席要离开公司,然后空降了一个新的执行主席感觉不是很妙啊....查看全文
皮神超级欧2021-02-23 21:26
$Glycomimetics(GLYC)$ 这股看走势得看周五的财报,如果在财报前有大反弹我估计就得撤,财报会带来崩盘的机会会大一点,如果低位震荡,那么就搏一把下周的爆发查看全文
$Glycomimetics(GLYC)$ 8-K Current report, item 3.01 Accession Number: 0001558370-24-009508 Act: 34 Size: 173 KB 网页链接
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017978 Size: 6 KB 网页链接
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017623 Size: 5 KB 网页链接
$Glycomimetics(GLYC)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-009140 Act: 34 Size: 182 KB 网页链接
$Glycomimetics(GLYC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-24-008882 Act: 34 Size: 8 MB 网页链接
$Glycomimetics(GLYC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007632 Act: 34 Size: 4 MB 网页链接
$Glycomimetics(GLYC)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000441 Act: 34 Size: 121 KB 网页链接
$Glycomimetics(GLYC)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001558370-24-006793 Act: 34 Size: 7 MB 网页链接
$Glycomimetics(GLYC)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001558370-24-006459 Act: 34 Size: 320 KB 网页链接
$Glycomimetics(GLYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-011860 Size: 5 KB 网页链接